Abstract Current research efforts require a broad range of immune reagents; those available for pigs are limited. The goal of the US-UK Collaborative Swine Immune Toolkit Initiative is to generate priority immune reagents, based on international input, and pipeline them for marketing. UK researchers focus on mucosal targets, including production of monoclonal antibodies (mAbs) to chemokine receptors and IgE. Plans for mAbs to each 7-transmembrane G-protein coupled receptor (CCR3, CCR9, CCR10, CXCR1, CXCR6, F4/80) are to target peptides from extracellular loop 2 (ECL-2) based on threaded protein structures. These peptides have been designed for CCR3 and CCR9 and mAb plans are underway. US efforts are aimed at expression of soluble proteins and swine CD molecules, and production of panels of mAbs. The team has set up collaborations with commercial partners for protein expression and mAb production, and updated protocols to evaluate reagent specificity. New panels of mAbs reactive with IL-6, IFNβ and IFNγ are currently being evaluated. Immunizations are underway to produce panels of mAbs for CXCL10, CX3CL1 (fractalkine), IL-13, IL-17A, IL-17F, IFNω1 and IFNω5. Plans for mAbs to porcine CD1d using 4 synthetic peptides are in progress using CD1d knockout (KO) mice and screening on CD1d KO pig cells. Plans continue to use reagents produced to develop new assays for swine immune markers, e.g., multiplex assays and intracellular staining to provide the veterinary community with new commercial reagents and techniques for their research efforts. Tools and reagents generated by this project will undoubtedly advance swine immune, disease and biomedical research efforts. Supported by USDA ARS, NIFA grant #2015-67015-23216 and BBSRC grant BB/M028232/1.
Read full abstract